미국의 상처 세척 시스템 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 부문별 예측(2025-2030년)

U.S. Wound Irrigation Systems Market Growth & Trends:

The U.S. wound irrigation systems market size is expected to reach USD 145.7 million by 2030, registering a CAGR of 3.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising cases of burn and chronic wounds, an increasing number of surgical procedures, technological advancements, and favorable initiatives taken by private and public sectors in the U.S. are the key driving factors for the market. Wound irrigation system allows rapid healing of deep wounds and surgical site infections.

It also allows improved wound cleansing that prevents further complications. The increasing cases of chronic wounds and the rising number of surgical procedures are projected to boost market growth. For instance, as per a report published by the ScienceDirect in 2018, the surgical infection has the highest prevalence rate of around 4.0%, followed by diabetic foot ulcers (3.4%) in the U.S. The rising number of traumatic cases and road accidents is another major factor likely to drive the market.

For instance, according to the American Association for the Surgery of Trauma, in 2017, around 1.2 million people died from road accidents in the U.S. Thus, such incidences are expected to boost the demand for rapid wound healing products. Moreover, increasing the incidence of burn cases is also anticipated to boost the demand for wound irrigation systems as such systems are highly effective in burn injuries.

U.S. Wound Irrigation Systems Market Report Highlights:

• Manual product segment held the largest market share in 2024 owing to the increased incidence of burns and surgical site infections across the country.
• Chronic wounds led the market in terms of revenue share in 2024, accounting for 33.7% of the global market, owing to the rising prevalence of diabetic foot ulcers, pressure ulcers, and venous leg ulcers.
• The wound care centers end-use segment is anticipated to witness the fastest CAGR over the forecast period owing to the increasing cases of chronic wounds

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Wound Irrigation System Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Wound Irrigation System Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Manual
  • 4.4.1. Manual Market, 2018 - 2030 (USD Million)
• 4.5. Battery-operated
  • 4.5.1. Battery-operated Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Wound Irrigation System Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Burns
  • 5.4.1. Burns Market, 2018 - 2030 (USD Million)
• 5.5. Chronic Wounds
  • 5.5.1. Chronic Wounds Market, 2018 - 2030 (USD Million)
  • 5.5.2. Diabetic Foot Ulcer
    • 5.5.2.1. Diabetic Foot Ulcer Market, 2018 - 2030 (USD Million)
  • 5.5.3. Venous Leg Ulcer
    • 5.5.3.1. Venous Leg Ulcer Market, 2018 - 2030 (USD Million)
  • 5.5.4. Pressure Ulcer
    • 5.5.4.1. Pressure Ulcer Market, 2018 - 2030 (USD Million)
• 5.6. Surgical Wounds
  • 5.6.1. Surgical Wounds Market, 2018 - 2030 (USD Million)
• 5.7. Traumatic Wounds
  • 5.7.1. Traumatic Wounds Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Wound Irrigation System Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 6.5. Ambulatory Surgery Centers
  • 6.5.1. Ambulatory Surgery Centers Market, 2018 - 2030 (USD Million)
• 6.6. Wound Care Centers
  • 6.6.1. Wound Care Centers Market, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. WestMed Products
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. BIONIX LLC
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. BD
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. CooperSurgical Inc.
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Stryker
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Essity Health & Medical
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Medline Industries, LP
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Zimmer Biomet
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives